Abnormal development of the inferior temporal region in fetuses with Down syndrome
Open accessAbstract
Down syndrome (DS) is a genetic condition associated with impairment in several cognitive domains. Previous evidence showed a notable neurogenesis reduction in the hippocampal region of DS fetuses, which may account for the impairment of declarative memory that characterizes DS starting from early life stages. The fusiform gyrus (FG) and the inferior temporal gyrus (ITG) play a key role in visual recognition memory, a function that is impaired in children and adults with DS. The goal of the current study was to establish whether fetuses with DS (17–21 weeks of gestation) exhibit neuroanatomical alterations in the FG and ITG that may underlie recognition memory impairment. We found that the FG and ITG of fetuses with DS had a reduced thickness and fewer cells in comparison with euploid fetuses. Moreover, DS fetuses had fewer cells expressing the neuronal marker NeuN than euploid fetuses, but a similar number of cells expressing the astrocytic marker GFAP and, consequently, a higher percentage of astrocytes. Immunohistochemistry for calretinin (CR), a marker of GABAergic interneurons, showed that in DS fetuses the ratio of CR‐positive vs. CR‐negative cells was greater than in euploid fetuses, both in the FG (177%) and ITG (161%). An increased ratio of CR‐positive vs. CR‐negative cells was also found in the entorhinal cortex, hippocampus and dentate gyrus. Results provide novel evidence that the FG and ITG of DS fetuses exhibit numerous developmental defects. These defects may underlie the functional alterations in visual recognition memory observed in children with DS.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several studies have shown that fewer interneurons are present in the cortex of individuals with Down syndrome than in controls, suggesting that reduced generation of interneurons contributes to the overall reduced neurogenesis in Down syndrome.
“Several studies have shown that fewer interneurons are present in the cortex of individuals with DS44,46,84 than in that of controls, suggesting that reduced generation of interneurons contributes to the overall reduced neurogenesis in DS.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [44]
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredAn increased number of astrocytes has been observed in the frontal lobe, fusiform gyrus, and inferior temporal gyrus of developing fetuses with Down syndrome compared to those without (17-21 weeks).
“An increased number of astrocytes has been observed in the frontal lobe (Zdaniuk et al., 2011), fusiform gyrus, and inferior temporal gyrus (Guidi et al., 2018) of developing fetuses with DS compared to those without (17–21 weeks).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Guidi et al., 2018
The Results section, “Density and percentage of neurons and astrocytes in the FG and ITG of fetuses with DS,” reports a similar absolute number of cells with an astrocytic phenotype in DS and euploid fetuses, not an increased number. It reports a higher percentage of astrocytes in both gyri. The frontal-lobe finding is attributed to a different citation in the citing sentence. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe presence of fewer cycling cells and the reduced number of progenitors both support the suggestion that neurogenesis is reduced during development in Down syndrome, although these data do not distinguish between slower progenitor proliferation or premature progenitor cell cycle exit.
“Together, the presence of fewer cycling cells and the reduced number of progenitors both support the suggestion that neurogenesis is reduced during development in DS, although these data do not distinguish between slower progenitor proliferation or premature progenitor cell cycle exit.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [44]
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredAnalyses of fetal brain tissue indicate that there are fewer proliferating cells, as measured by expression of the cell cycle marker Ki67 and of cyclin proteins, in the germinal zones of the hippocampus and cortex in Down syndrome.
“Analyses of fetal brain tissue indicate that there are fewer proliferating cells, as measured by their expression of the cell cycle marker Ki67 and of cyclin proteins, in the germinal zones of the hippocampus and cortex in DS40,42–44,47,50,64.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [44]
The section “Abnormal architecture and reduced neuron number in the FG and ITG of DS fetuses” reports a previously observed reduction in proliferating neural precursors in the germinal matrix of DS fetuses. The Abstract also notes reduced neurogenesis in the hippocampal region. Neither passage says that proliferation in both hippocampal and cortical germinal zones was measured using Ki67 and cyclin proteins. (LLM, conf=0.85)
Experimental — accuracy not yet measuredIncreased numbers of astrocytes have been reported in the fetal brain in individuals with Down syndrome.
“Increased numbers of astrocytes have been reported in the fetal brain in individuals with DS42,44,99 (Fig. 1).”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [44]
In “Abnormal architecture and reduced neuron number in the FG and ITG of DS fetuses” (page not provided), the paper reports a relative increase in GFAP-positive astrocytes in the fetal hippocampus. But its own FG and ITG results found similar absolute numbers of GFAP-positive cells in DS and euploid fetuses; the increased S100B-positive cells cannot all be identified as astrocytes because S100B also marks other glia. The claim therefore overstates the evidence for increased astrocyte numbers in the fetal brain. (LLM, conf=0.86)
Experimental — accuracy not yet measured
The fetal cortex, cerebellum and hippocampus have all been shown to contain fewer neurons in individuals with Down syndrome than in controls, albeit based on small sample sizes.
“The fetal cortex, cerebellum and hippocampus have all been shown to contain fewer neurons in individuals with DS than in controls40–48, albeit based on small sample sizes17.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [44]
The section ‘Abnormal architecture and reduced neuron number in the FG and ITG of DS fetuses’ reports fewer neurons in two cortical regions and describes a previously reported reduction in the fetal hippocampal region. The Subjects section reports six DS and six euploid fetuses. Our copy does not establish the claimed reduction in the cerebellum, so this source supports only part of the three-region statement. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe finding of increased calretinin positive interneuron proportion without increases in interneuron number was repeated in the entorhinal cortex and hippocampus in Down syndrome.
“This finding of increased calretinin positive interneuron proportion without increases in interneuron number, was repeated in the entorhinal cortex and hippocampus (Guidi et al., 2018).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Guidi et al., 2018
The section “Increased number of calretinin-positive cells in the ventral temporal lobe of DS fetuses” reports a higher proportion of calretinin-positive cells in the entorhinal cortex and parts of the hippocampal region. It also reports an exception to the claim that their number did not increase: DS fetuses had more calretinin-positive cells in the dentate gyrus granule cell layer and CA1 stratum pyramidale. No page number is provided in the supplied passages. (LLM, conf=0.90)
Experimental — accuracy not yet measuredIn the cortical plate in the developing fusiform gyrus and inferior temple gyrus (17-21 weeks gestation), there was no significant difference in the number of calretinin positive interneurons between fetuses with Down syndrome and those without, but due to a decrease in number of calretinin negative cells, the proportion of calretinin positive interneurons to the total number of neurons was higher
“There was no significant difference in the number of calretinin positive interneurons between fetuses with DS and those without, but due to a decrease in number of calretinin negative cells, the proportion of calretinin positive interneurons to the total number of neurons was higher in the samples from individuals with DS (Guidi et al., 2018).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Guidi et al., 2018
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611 · see citing works
Carlesimo, G. A., Marotta, L., & Vicari, S. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00055-3 · Cited by 211 · see citing works
Bianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., Fernandez, M., Giuliani, A., Calza, L., & Bartesaghi, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0534-10.2010 · Cited by 188 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [2]2. Barinka F, Druga R (2010) Calretinin expression in the mammalian neocortex: a review. Physiol Res 59 :665-677.
Cited by
Sorted by citations
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48 · see citing works
Neurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47 · see citing works
“This finding of increased calretinin positive interneuron proportion without increases in interneuron number, was repeated in the entorhinal cortex and hippocampus (Guidi et al., 2018).”
BackgroundInfluentialAltered patterning of trisomy 21 interneuron progenitors
Giffin-Rao, Y., Sheng, J., Strand, B., Xu, K., Huang, L., Medo, M., Risgaard, K. A., Dantinne, S., Mohan, S., Keshan, A., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.001 · Cited by 38 · see citing works
Consequences of trisomy 21 for brain development in Down syndrome
Russo, M. L., Sousa, A. M. M., & Bhattacharyya, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00866-2 · Cited by 28 · see citing works
“Several studies have shown that fewer interneurons are present in the cortex of individuals with DS 44,46,84 than in that of controls, suggesting that reduced generation of interneurons contributes to the overall reduced neurogenesis in DS. Interneurons are generated from progenitors located in the…”
InfluentialComprehensive volumetric phenotyping of the neonatal brain in Down syndrome
Fukami-Gartner, A., Baburamani, A. A., Dimitrova, R., Patkee, P. A., Ojinaga-Alfageme, O., Bonthrone, A. F., Cromb, D., Uus, A. U., Counsell, S. J., Hajnal, J. V., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad171 · Cited by 24 · see citing works
Ishihara, K. (2021) · Genes · doi:10.3390/genes12101598 · Cited by 8 · see citing works
Postnatal Cytoarchitecture and neurochemical hippocampal dysfunction in Down Syndrome
Moreno, D. G., Utagawa, E. C., Arva, N. C., Schafernak, K. T., Mufson, E. J., & Perez, S. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153414 · Cited by 7 · see citing works
- Authors
- Guidi, S., Giacomini, A., Stagni, F., Emili, M., Uguagliati, B., Bonasoni, M. P., & Bartesaghi, R.
- Affiliations
- University of Bologna (IT)
- Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
- ORCID
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2018-07-05
- Volume
- 28
- Issue
- 6
- Pages
- 986-998
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- PMC
- PMC8028380
- OpenAlex
- W2791044485
- Cited by
- 47
- References
- 3
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 7 · 2023: 4 · 2022: 10 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 2
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione del Monte, Bologna, Italy
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Down syndrome, fetal brain development, inferior temporal gyrus, fusiform gyrus, visual recognition memory, calretinin, GABAergic interneurons, astrocytes, NeuN, glial fibrillary acidic protein, entorhinal cortex, hippocampus, dentate gyrus, neuroanatomical changes
- MeSH terms
- Astrocytes, Cell Count, Cerebral Cortex, Down Syndrome, Female, Fetus, Hippocampus, Humans, Interneurons, Male, Temporal Lobe, Recognition, Psychology, Fetal Development, Neurogenesis, GABAergic Neurons, Calbindin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review